Premium
Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy
Author(s) -
Gorphe Philippe,
Matias Margarida,
Blanchard Pierre,
Even Caroline,
Ferte Charles,
Tao Yungan,
Temam Stéphane,
Bidault François,
Janot François
Publication year - 2017
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.26425
Subject(s) - medicine , laryngectomy , induction chemotherapy , larynx , radiation therapy , chemotherapy , cancer , surgery , retrospective cohort study , cohort , multivariate analysis , stage (stratigraphy) , oncology , paleontology , biology
Objective To review patients who refused a total laryngectomy and were treated with radiotherapy (RT) after insufficient response to induction chemotherapy in a larynx preservation protocol for advanced‐stage cancer of the larynx and to compare their outcomes with good responders. Study Design Retrospective cohort study. Methods Eighty‐six patients treated with induction chemotherapy followed by RT were included in the analysis: 75 good responders and 11 insufficient responders who refused surgery. We compared overall survival (OS), disease‐free survival (DFS), and laryngo‐esophageal dysfunction‐free survival (LEDFS) of the cohort populations in univariate and multivariate analyses. Results The median follow‐up was 44 months. The 2‐year and 5‐year survival rates were respectively 72.2% and 58.8% for OS, 62.8% and 49.4% for DFS, and 59.5% and 44.3% for LEDFS. No survival endpoint was significantly decreased among insufficient responders, contrary to what we expected. When we focused on patients with an initially fixed larynx, the recovery of larynx mobility after induction chemotherapy was not associated with OS ( P = 0.6055), DFS ( P = 0.459), or LEDFS ( P = 0.7403). Conclusion To the best of our knowledge, our study is the first patient treatment evaluation focused on subjects who refused a total laryngectomy after insufficient response to induction chemotherapy in a larynx preservation protocol for advanced‐stage cancer of the larynx. Surprisingly, these patients treated with RT in our cancer center did not experience decreased functional and oncologic outcomes compared to good responders. Further studies will explore the relevance of response criteria and their evaluation methods. Level of Evidence 4. Laryngoscope , 127:1791–1796, 2017